SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is surging as strong Azure cloud growth and a clear focus on AI monetization help soothe investor anxiety regarding capital expenditures. The community is actively debating whether this performance marks a broader market turnaround or if it will be hindered by headwinds from other underperforming big-tech names.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the company's announcement of marketing authorization in the UAE for Anktiva, which marks a significant expansion of its regulatory footprint into its 34th country. Community sentiment is mixed, with long-term investors highlighting the broader global validation of the drug while others express frustration over the timing of news delivery and persistent short interest.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor attention driven by a series of upsized, AAA-rated ABS deals and positive credit outlooks, leading many in the community to highlight the company's strong fundamentals and undervalued valuation relative to fintech peers. Despite this performance, the stock faces ongoing volatility from macro headwinds and persistent short-selling, causing retail investors to debate whether the current price represents a prime accumulation zone ahead of upcoming earnings.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is facing downward pressure as investors react to disappointing full-year guidance and concerns over net yield, which overshadowed a reported earnings beat. While the stock is struggling with negative sentiment and fuel cost volatility, the community remains divided, with some investors viewing the price drop as a buying opportunity based on long-term turnaround potential and strategic leadership changes.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing sharp downward pressure as investors express concerns over the company's aggressive capital expenditure plans and limited near-term visibility into AI monetization. While some community members view the pullback as a potential buying opportunity given the company's strong ad revenue fundamentals, others are actively debating whether the high spending levels will yield sufficient returns or continue to erode free cash flow.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is surging following a blockbuster earnings report that featured record revenue and raised full-year guidance, fueled by intense demand for onsite power from AI hyperscalers. The community is actively debating the stock's future trajectory, weighing the impressive fundamental growth against broader market volatility and institutional influence.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to upcoming Q3 data readouts for its VK2735 obesity drug, with investors closely watching the maintenance dosing study and oral pipeline progress. While community sentiment is divided between optimism over the drug's best-in-class potential and frustration regarding the CEO's communication style, insider activity, and potential future share dilution, significant interest persists in the firm's strategic path toward commercialization or a potential partnership.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is facing intense scrutiny as analysts slash price targets following a lackluster quarter, with the market increasingly skeptical of the company's ability to maintain margins amidst rising costs and the loss of key modem revenue. Despite leadership's efforts to pivot toward data centers and automotive AI to offset these headwinds, the community remains divided between those betting on long-term diversification and investors frustrated by persistent stock price stagnation and intense volatility.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing heightened activity as investors weigh the company's QNX software potential in the robotics and automotive sectors against recent institutional selling and management's share activity. While some community members are bullish on upcoming technological partnerships and the potential for a rebound, others are voicing deep frustration over the stock's recent volatility and the lack of concrete updates on key partnership milestones.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense downward pressure driven by broader AI infrastructure volatility and sector-wide margin call fears, leading the community to debate whether this represents a long-term buying opportunity or a deeper correction. Despite the price volatility, investors remain focused on upcoming earnings and potential hyperscaler partnerships as key indicators of the company's long-term growth trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Steve

Full Name

Brian

StockTwits for iOS

Exact Sciences Corp.

Abbott Laboratories

thingkfast

@thingkfast abbott snagged a hell of a deal. Guardant market cap is currently sitting at the acquisition price, and exact pretty much now has its own shield. There was a mention of the next gen oncodetect on the call too

 abbott snagged a hell of a deal. Guardant market cap is currently sitting at the acquisition price, and exact pretty much now has its own shield. There was a mention of the next gen oncodetect on the call too

@thingkfast false. Anyone that works there knows they did

 false. Anyone that works there knows they did

Enjoy Life

@Enjoy_Life_Bro multiple products. Cancerguard reimbursement in a few years, launch in other countries…Cologuard rescreens compounding, launch in other countries…

It will be a slow burn but I think worthwhile

 multiple products. Cancerguard reimbursement in a few years, launch in other countries…Cologuard rescreens compounding, launch in other countries…

It will be a slow burn but I think worthwhile